Cargando…
Rapid proteomic analysis for solid tumors reveals LSD1 as a drug target in an end‐stage cancer patient
Recent advances in mass spectrometry (MS)‐based technologies are now set to transform translational cancer proteomics from an idea to a practice. Here, we present a robust proteomic workflow for the analysis of clinically relevant human cancer tissues that allows quantitation of thousands of tumor p...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068348/ https://www.ncbi.nlm.nih.gov/pubmed/29901861 http://dx.doi.org/10.1002/1878-0261.12326 |